PMDA drug package insert
デキサート注射液1.65mg
PMDA Prescription drug · 富士製薬工業株式会社 · package insert Apr 22, 2026
Key facts
| Brand names | デキサート注射液1.65mg, デキサート注射液3.3mg, デキサート注射液6.6mg |
|---|---|
| Nonproprietary names | デキサメタゾンリン酸エステルナトリウム |
| Companies | 製造販売元／富士製薬工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 副腎皮質ホルモン製剤 |
| Therapeutic category codes | 872454 |
| YJ codes | 2454405H1032, 2454405H3035, 2454405H5038 |
| Approval numbers | 22100AMX01403, 22100AMX01404, 22100AMX01402 |
| Package insert edition | 第3版 |
| Package insert date | Apr 22, 2026 |
| PMDA document key | 670109_2454405H1032_1 |
| PMDA company code | 670109 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: